Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information As per section 4.2.8 of the topic selection manual Generic or biosimilar medicines are not eligible to be considered if the branded version is recommended in NICE technology appraisal or highly specialised technologies guidance (see the European Medicines Agency's definitions of generic medicines and biosimilar medicine). This is because the recommendation usually applies to the generic or biosimilar medicine.
ID number 11790

Project Team

Project lead Danielle Lees

Email enquiries

For further information on how we select topics for development, please see our page about topic selection